CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 73 enrolled
Drug / intervention
Cryoablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02511678
NCT02511678N/ACompleted

Multicenter Study of Cryoablation for Palliation of Painful Bone Metastases

Boston Scientific Corporation·interventional·Posted Jul 30, 2015·Updated Jul 19, 2021

In Brief

A clinical study evaluating Cryoablation for Pain and 2 related conditions. Completed, enrolled 73 participants across 11 sites in 2 countries.

Detailed Summary

This study will evaluate the efficacy of cryoablation for palliation of painful metastases in participants with metastatic lesions involving bone who have failed, are not candidates for, or are not experiencing adequate pain relief from current pain therapies (for example, radiation, analgesics).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance, United States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 30, 2015
Enrollment StartFeb 15, 2016
Primary CompletionMar 12, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 10.9 years ago

Interventions

Cryoablationdevice

The application of repeated freeze and thaw cycles to the identified tissues.